![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Show more
Aileron Therapeutics to be Included in the Russell Microcap® Index PR Newswire AUSTIN, Texas, July 1, 2024 AUSTIN, Texas, July 1, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron" or the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -1.06007067138 | 2.83 | 3.1 | 2.5 | 32762 | 2.69229501 | CS |
4 | -0.17 | -5.72390572391 | 2.97 | 3.3 | 2.5 | 65749 | 2.9463462 | CS |
12 | -0.99 | -26.1213720317 | 3.79 | 4.17 | 2.5 | 72940 | 3.24154686 | CS |
26 | -2.27 | -44.7731755424 | 5.07 | 7.42 | 2.5 | 76383 | 4.24118081 | CS |
52 | 0.89 | 46.5968586387 | 1.91 | 7.42 | 1.01 | 74663 | 3.7383215 | CS |
156 | -18.2 | -86.6666666667 | 21 | 25.4 | 1.01 | 289075 | 9.21199617 | CS |
260 | -7 | -71.4285714286 | 9.8 | 49.4 | 1.01 | 620958 | 22.82159314 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions